Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Interest Expenses (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Interest Expenses readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 2.74% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 1.22% increase, with the full-year FY2025 number at $5.3 million, up 1.22% from a year prior.
  • Interest Expenses hit $1.3 million in Q4 2025 for Treace Medical Concepts, up from $1.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.3 million in Q4 2025 to a low of $946000.0 in Q2 2022.
  • Median Interest Expenses over the past 5 years was $1.3 million (2023), compared with a mean of $1.2 million.
  • Biggest five-year swings in Interest Expenses: surged 133.79% in 2021 and later dropped 8.86% in 2022.
  • Treace Medical Concepts' Interest Expenses stood at $1.0 million in 2021, then grew by 27.53% to $1.3 million in 2022, then dropped by 0.53% to $1.3 million in 2023, then grew by 0.77% to $1.3 million in 2024, then grew by 2.74% to $1.3 million in 2025.
  • The last three reported values for Interest Expenses were $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.